How would you approach evaluation and treatment of a patient on pembrolizumab therapy who presents with symmetric, proximal, upper extremity and lower extremity painful weakness without an elevated CK?   

Answer from: at Academic Institution
at Duke University Medical Center
Would also evaluate for any signs of myocardial in...
Sign in or Register to read more